S. Hay

发表

Peroxidase enzymes inhibit osteoclast differentiation and bone resorption

A. Evdokiou, D. Leach, V. Panagopoulos, 2017, Molecular and Cellular Endocrinology.

Expression of fibrillins and other microfibril-associated proteins in human bone and osteoblast-like cells.

A. Evdokiou, S. Kitahama, G. Atkins, 2000, Bone.

Enhanced Apoptosis of Soft Tissue Sarcoma Cells with Chemotherapy: A Potential New Approach Using Trail

A. Evdokiou, M. Clayer, G. Atkins, 2001, Journal of orthopaedic surgery.

Doxorubicin overcomes resistance to drozitumab by antagonizing Inhibitor of Apoptosis Proteins (IAPs).

V. Ponomarev, A. Evdokiou, V. Panagopoulos, 2014, Anticancer research.

Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivo

V. Ponomarev, A. Evdokiou, A. Zannettino, 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Zoledronic Acid Inhibits Both the Osteolytic and Osteoblastic Components of Osteosarcoma Lesions in a Mouse Model

V. Ponomarev, A. Evdokiou, D. Findlay, 2009, Clinical Cancer Research.

Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancer

V. Ponomarev, A. Evdokiou, A. Zannettino, 2009, Molecular Cancer Therapeutics.

Uncovering a new role for peroxidase enzymes as drivers of angiogenesis.

A. Evdokiou, D. Leach, V. Panagopoulos, 2015, The international journal of biochemistry & cell biology.

Induction of cell death of human osteogenic sarcoma cells by zoledronic acid resembles anoikis.

A. Evdokiou, D. Findlay, A. Labrinidis, 2003, Bone.

Circulating RANKL is inversely related to RANKL mRNA levels in bone in osteoarthritic males

N. Fazzalari, M. Chehade, D. Findlay, 2008, Arthritis research & therapy.

Adoptive transfer of ex vivo expanded Vγ9Vδ2 T cells in combination with zoledronic acid inhibits cancer growth and limits osteolysis in a murine model of osteolytic breast cancer.

V. Ponomarev, A. Evdokiou, V. Panagopoulos, 2017, Cancer letters.

Anticancer efficacy of the hypoxia‐activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma

V. Ponomarev, A. Evdokiou, V. Panagopoulos, 2017, Cancer medicine.

Human osteoblasts are resistant to Apo2L/TRAIL-mediated apoptosis.

A. Evdokiou, A. Zannettino, D. Haynes, 2002, Bone.

Hypoxia-activated pro-drug TH-302 exhibits potent tumor suppressive activity and cooperates with chemotherapy against osteosarcoma.

V. Ponomarev, A. Evdokiou, V. Panagopoulos, 2015, Cancer letters.

Zoledronic acid protects against osteosarcoma‐induced bone destruction but lacks efficacy against pulmonary metastases in a syngeneic rat model

A. Evdokiou, D. Findlay, A. Labrinidis, 2010, International journal of cancer.

Expression of Osteoclast Differentiation Signals by Stromal Elements of Giant Cell Tumors

A. Evdokiou, D. Haynes, S. Graves, 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of bone.

S. Geary, A. Evdokiou, A. Zannettino, 2001, Bone.

Systematic in vitro nanotoxicity study on anodic alumina nanotubes with engineered aspect ratio: understanding nanotoxicity by a nanomaterial model.

A. Evdokiou, D. Losic, Ye Wang, 2015, Biomaterials.

Apo2l/Tumor necrosis factor-related apoptosis-inducing ligand prevents breast cancer-induced bone destruction in a mouse model.

B. Coventry, A. Evdokiou, D. Findlay, 2006, Cancer research.

Apo 2 L / TRAIL Inhibits Tumor Growth and Bone Destruction in aMurineModel of Multiple Myeloma

V. Ponomarev, A. Evdokiou, Sally K. Martin, 2009 .

The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL

L. Butler, W. Tilley, A. Evdokiou, 2006, International journal of cancer.

Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy

A. Evdokiou, G. Atkins, A. Labrinidis, 2003, British Journal of Cancer.

143 osteosarcoma cells to Apo 2 L / TRAIL-induced apoptosis is mediated by acquisition of DcR 2 / TRAIL-R 4 expression : resensitisation with chemotherapy

A. Evdokiou, A. Labrinidis, S. Hay, 2003 .

Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to apo2l/trail‐induced apoptosis

A. Evdokiou, M. Clayer, D. Findlay, 2002, International journal of cancer.

Highly biocompatible carbon nanocapsules derived from plastic waste for advanced cancer therapy

A. Alhadhrami, A. Aldalbahi, D. Losic, 2017 .

Peroxidase Enzymes Regulate Collagen Biosynthesis and Matrix Mineralization by Cultured Human Osteoblasts

A. Evdokiou, V. Panagopoulos, D. Findlay, 2016, Calcified Tissue International.

Sensitivity of fresh isolates of soft tissue sarcoma, osteosarcoma and giant cell tumour cells to Apo2L/TRAIL and doxorubicin.

A. Evdokiou, M. Clayer, S. Graves, 2004, International journal of oncology.

Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow

S. Gronthos, A. Zannettino, S. Shi, 2003, Journal of Cell Science.

Differential Cell Surface Expression of the STRO‐1 and Alkaline Phosphatase Antigens on Discrete Developmental Stages in Primary Cultures of Human Bone Cells

S. Gronthos, A. Zannettino, P. Simmons, 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Zoledronate Enhances the Cytotoxicity of Gamma Delta T Cell Immunotherapy in an Orthotopic Mouse Model of Osteolytic Osteosarcoma

V. Ponomarev, A. Evdokiou, V. Panagopoulos, 2018 .

Apo2L/TRAIL Inhibits Tumor Growth and Bone Destruction in a Murine Model of Multiple Myeloma

V. Ponomarev, A. Evdokiou, A. Zannettino, 2009, Clinical Cancer Research.

Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer

V. Ponomarev, A. Evdokiou, V. Panagopoulos, 2014, International journal of oncology.

Does Apo2L/TRAIL play any physiologic role in osteoclastogenesis?

A. Evdokiou, A. Zannettino, N. Sims, 2008, Blood.

Titanium wire implants with nanotube arrays: A study model for localized cancer treatment.

A. Evdokiou, K. Gulati, D. Losic, 2016, Biomaterials.

A method for production and characterization of metal prosthesis wear particles

D. Howie, M. Pearcy, A. Bramley, 1993, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.